Skip to main content

Table 1 Comparative analysis of baseline data

From: Comparison of the clinical and prognosis risk factors between endoscopic resection and radical gastrectomy for early-stage gastric cancer

Characteristic

ESD/EMR (n = 139)

LARG (n = 108)

ORG (n = 170)

P

Sex (%)

   

0.07

 Male

113 (81.3)

76 (70.3)

121 (71.2)

 

 Female

26 (18.7)

32 (29.7)

49 (28.8)

 

Year (%)

   

0.21

  ≥ 60

91 (65.5)

59 (54.6)

101 (59.0)

 

  < 60

48 (34.5)

49 (45.4)

69 (41.0)

 

Smoking (%)

24 (17.3)

22 (20.4)

31 (18.2)

0.47

Drink (%)

14 (10.0)

13 (12.0)

18 (10.6)

0.88

Angiosis (%)

26 (18.7)

19 (17.6)

31 (18.2)

0.97

Diabetes (%)

5 (3.6)

3 (2.8)

7 (4.1)

0.94*

Family history (%)

4 (2.9)

3 (2.8)

5 (2.9)

0.99*

Weight (kg)

60 (55–68)

63 (58–68)

61 (55–68)

0.32

WBC (109/ml)

5.4 (4.8–5.5)

5.4 (4.9–6.2)

61 (55–68)

0.32

NE (109/ml)

2.9 (2.4–3.7)

3.31 (2.5–4.0)

3.1 (2.6–3.9)

0.13

HB (g/L)

133 (124–143)

135 (122–145)

133 (120–144)

0.64

RBC (1012/ml)

4.4 (4.1–4.7)

4.4 (4.1–4.7)

4.4 (4.1–4.7)

0.95

PLT (109/ml)

189 (155–234)

197 (159–241)

182 (145–221)

0.10

ALB (g/L)

42 (40–45)

43 (40–45)

43 (40–46)

0.47

AFP (ng/ml)

2.2 (1.9–3.0)

2.2 (1.6–3.4)

2.4 (1.6–3.3)

0.76

CEA (ng/ml)

2.1 (1.3–3.0)

2.3 (1.3–3.3)

1.9 (1.3–2.9)

0.56

CA125 (U/ml)

8.9 (7.0–10.9)

9.3 (6.4–14.0)

9.4 (7.2–13.1)

0.13

CA199 (U/ml)

7.7 (5.1–9.9)

8.2 (5.3–14.3)

8.4 (5.2–12.2)

0.16

  1. Data are expressed as M (P25 and P75) or number (%)
  2. ESD Endoscopic mucosal dissection, EMR Endoscopic mucosal resection, LARG Laparoscopic assisted radical gastrectomy, ORG Open radical gastrectomy
  3. *Fisher’s exact test was used. Angiosis: atherosclerotic lesions of the heart or brain. Family history: the patient had familial gastric cancer in his immediate family